Exciting Development in Search for Hepatitis C Vaccine
Protein Analysis Could Lead To Hepatitis C Vaccine
redOrbit Staff & Wire Reports – Your Universe Online
A hepatitis C vaccine is one step closer thanks to the efforts of scientists at The Scripps Research Institute (TSRI), who have managed to discover unexpected structural features of a protein used by the virus to infect liver cells.
The study authors, whose work appears in Friday’s edition of the journal Science, state any successful hepatitis C vaccine would most likely target this protein, which is known as E2 envelope glycoprotein. Rare antibodies capable of binding E2 in ways that can neutralize a vast array of different viral strains have already been isolated in patients by scientists, they added.
Continue reading this entire article:
Breaking News: FDA Approves New Treatment for Hep C (Genotype 1)
Patient Enrollment Started in the Phase II HELIX-2 Clinical Trial